# Blackrock Microsystems

- Location (FDA's records): Salt Lake City, UT
- FDA decisions: 3 (2011–2021): 3 510(k) clearances
- Names in FDA's records: Blackrock Microsystems (2); Blackrock Microsystems, Inc. (1)
- Product codes: GZL (1), GYC (1), GWL (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cyberkinetics Neurotechnology Systems, Inc.: 1 (https://510kreport.com/company/cyberkinetics-neurotechnology-systems)
- Ad-Tech Medical Instrument Corp: 1 (https://510kreport.com/company/ad-tech-medical-instrument)
- I2s Micro Implantable Systems, LLC: 1 (https://510kreport.com/company/i2s-micro-implantable-systems)

## Recent decisions
- K202174: Digital NeuroPort Biopotential Signal Processing System (Feb 10, 2021)
- K191346: Blackrock NeuroCoG Subdural Cortical Electrodes (Strips and Grids) (Feb 14, 2020)
- K110010: Neuroport Cortical Microelectrode Array System (Feb 9, 2011)

Source page: https://510kreport.com/company/blackrock-microsystems